Anlon Healthcare Limited

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about the transcript of the Q1 FY27 Earnings Conference call, which was held on August 6, 2026. The company's EBITDA margin moderated to approximately 17% due to a sharp increase in raw material prices and the consolidation of Remember India Health links' operating expenses. The company expects EBITDA margins to gradually recover and stabilize in the 25% to 30% range during Q2 and Q3 of FY27. The company has completed the acquisition of a 63.98% stake in Remember India Health links, which provides access to over 30 formula dossiers.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about the Share Swap Agreement (SSA) with Apiqo Organics Private Limited and Bizotic Lifescience Private Limited to acquire up to 32.52% and 43.33% shareholding respectively in lieu of issuance and allotment of fresh equity shares on a preferential basis.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about the link of recording for the Q1/FY-27 Earnings Conference Call with Investor(s)/Analyst(s). The audio recording is available on the company's website.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about Investor Presentation for Q1 & FY - 27, which is uploaded on their website. The presentation includes information on the company's transformational acquisitions, capacity expansion, and growth prospects.

Anlon Healthcare Limited

Anlon Healthcare Limited has published its unaudited standalone financial results for the quarter ended June 30, 2026, showing a net loss of Rs. 725 million.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about a scheduled earnings conference call to discuss the audited Financial Results for the Quarter ended June 30, 2026.

Anlon Healthcare Limited

Anlon Healthcare Limited has reported a 163% year-on-year growth in consolidated Total Income to ₹87.62 Crore, 150% growth in EBITDA to ₹15.65 Crore, and 133% growth in Profit After Tax to ₹8.28 Crore for Q1FY27.

Anlon Healthcare Limited

Anlon Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors also approving the acquisition of 32.52% shareholding in Apiqo Organics Private Limited and 43.33% shareholding in Bizotic LifeScience Private Limited through a share swap arrangement.

Anlon Healthcare Limited

Anlon Healthcare Limited has announced its unaudited financial results for the quarter ended June 30, 2026, and has also approved a share swap arrangement with Apiqo Organics Private Limited and Bizotic LifeScience Private Limited to acquire 32.52% and 43.33% shareholding in these entities respectively.

Anlon Healthcare Limited

Anlon Healthcare Limited has submitted a Structured Digital Database (SDD) Compliance Certificate for the quarter ended June 30, 2026, as per the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, with attached certificates from KFIN TECHNOLOGIES LIMITED and CENTRAL DEPOSITORY SERVICES (INDIA) LIMITED.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about the incorporation of its subsidiary, Anlon Biologics Private Limited, with effect from July 10, 2026, as part of its strategy to expand its business in the pain management segment.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange about the incorporation of a subsidiary, ANLON MEDICARE PRIVATE LIMITED, with effect from July 09, 2026.

Anlon Healthcare Limited

Anlon Healthcare Limited's Chairman & Managing Director, Punitkumar Rasadia, participated in an interview/podcast with Sumit Mehrotra, former Senior Anchor @cnbcawaaz, discussing company business performance, industry outlook, operational updates, growth strategy, and future plans.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding an interview of Chairman & Managing Director with Money TV, where he discussed the company's business performance, industry outlook, operational updates, growth strategy, and future plans, but no unpublished price sensitive information was shared.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on July 01, 2026, where the Board of Directors has accorded its consent for incorporation of two subsidiary companies, ANLON MEDICARE PRIVATE LIMITED and ANLON BIOLOGICS PRIVATE LIMITED, and also approved changing the name of an existing subsidiary company from REMEMBER INDIA HEALTH LINKS PRIVATE LIMITED to ANLON MEDICOS PRIVATE LIMITED.

Anlon Healthcare Limited

Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Anlon Healthcare Limited

Anlon Healthcare Limited has provided a clarification to the National Stock Exchange regarding the company's financial results for the quarter ended June 30, 2025, addressing queries related to the submission of machine-readable form and covering letter with the financial results.